Frontier Medical Group is a diversified medical devices business focused on the Skin/Wound Care and Infection Prevention markets. The business’ Skin/Wound Care brands include Repose®, Toto® and DermisPlus® which are used in the prevention and treatment of pressure ulcers (bed sores) and treatment of wounds. Through its Infection Prevention division, the business produces a range of sharps and clinical waste containers (Sharpsafe® and Clinisafe) for the safe disposal of medicinal sharps, pharmaceuticals and other clinical waste. Frontier has an established direct sales team in the UK and has recently invested in direct sales teams in the US and Germany to complement it’s expanding global distributor network.
Frontier Medical Group was sold to Agilitas Private Equity in June 2021, delivering a return of 3.4x to Kester Capital funds and a 30% IRR.
www.frontier-group.co.uk
Location: Argentina, Mendoza